Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +1.73% advanced 1.97% to $339.57 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -1.92% rising 0.62% to 15,215.70 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.17% falling 0.02% to 35,603.08. The stock's rise snapped a two-day losing streak. Moderna Inc. closed $157.92 short of its 52-week high ($497.49), which the company achieved on August 10th.
The stock outperformed some of its competitors Thursday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +1.69% rose 0.32% to $108.76, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.63% fell 0.32% to $208.99, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN -1.02% rose 0.97% to $61.22. Trading volume (5.5 M) remained 8.9 million below its 50-day average volume of 14.4 M.